Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - tadalafil - zaburzenia erekcji - urologiczne - leczenie zaburzeń erekcji u dorosłych mężczyzn. aby tadalafil był skuteczny, wymagana jest stymulacja seksualna. tadalafil lilly nie jest wskazany do stosowania przez kobiety. leczenie objawów łagodnego rozrostu gruczołu krokowego u mężczyzn.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - nowotwory piersi - Środki przeciwnowotworowe - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - galcanezumab - choroby migreny - analgesics, galcanezumab - emgality wskazany jest w profilaktyce migreny u dorosłych, którzy mają co najmniej 4 dni migreny w miesiącu.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - glukagon - cukrzyca - hormony trzustki, hormony glycogenolytic - baqsimi jest wskazany w leczeniu ciężkiej hipoglikemii u dorosłych, młodzieży i dzieci w wieku od 4 lat i starszych z cukrzycą.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - insulina lispro - cukrzyca - leki stosowane w cukrzycy - leczenie cukrzycy u dorosłych, młodzieży i dzieci w wieku 1 roku i powyżej. leczenie cukrzycy u dorosłych.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - Środki przeciwnowotworowe - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - leki stosowane w cukrzycy - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 i 5.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - choroby migreny - Środki przeciwbólowe - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - zapalenie okrężnicy, wrzodziejące - leki immunosupresyjne - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - chłoniak, mantle-cell - inhibitory białka kinazy - treatment of mantle cell lymphoma (mcl).